You have successfully sign out
Loading...
60 Degrees Pharmaceuticals, Inc.
SXTP
Company Description
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
NASDAQ
Unprofitable
Unprofitable
2.12USD
-0.13 ( -5.78%)
Pre-market 2.31$
0.20 (9.20%)Market Closed (as of Feb 24, 21:00 EDT)
Relative Strenght
92
Volume Buzz
-90%
Earning Acce
Yes
Dist 52w H.
94%
